Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15A pseudogene 32 (RPS15AP32) is a processed pseudogene related to the ribosomal protein S15A gene family. Pseudogenes like RPS15AP32 are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition events, lack protein-coding ability due to mutations or deletions, and do not produce functional products[4][5]. Multiple processed pseudogenes exist for ribosomal protein genes because these genes are highly expressed and prone to retrotransposition, but the pseudogenes do not participate in ribosome formation or cellular protein synthesis. No therapeutic, diagnostic, or biological functions are attributed to RPS15AP32, and it is not considered a drug target or biomarker. The provided target, RPS15AP32, is not a protein, receptor, enzyme, or functional gene product; it is a pseudogene. There is no actionable biology, therapeutic relevance, or druggability associated with it based on current knowledge[4][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15A pseudogene 32 (RPS15AP32).